As an asset class with a buy-to-sell cycle that typically lasts around five to seven years, you would be forgiven for thinking that private equity could weather the storm of Covid-19 more smoothly than other, more inherently volatile asset classes, can. That’s partly true.
Sparked by the rapid pace of innovation, the business of managing money is being reshaped by five key trends Find out how firms can meet the challenges head-on.
German family-equity company Haniel has become a regional cornerstone investor of Gilde Investment Management's Gilde Healthcare V fund.
ARX Equity Partners has sold its investment in Slovenian healthcare services provider Diagnosticni Center Bled doo (DCB), generating an overall 3.6x cash-on-cash return multiple and an IRR exceeding 25 per cent.
Kenyan health tech startup Afya Rekod is about to launch an AI and blockchain consumer-driven, health data platform in support of global efforts to curb the coronavirus pandemic.
With the US presidential election campaign rapidly gathering pace, the issue of political contributions – and the potential for conflicts of interest – has become a major issue on fund managers’ compliance radars.
Covid-19 fallout continues to hit firms across the world, both in terms of supply and demand, and the predicted ensuing recession is likely to change how we live in the future. While the outbreak has unsettled lives and businesses across the world, delaying deal processes and fundraising, there are ‘new world’ sectors that will do well.
ESG engagement by European firms is "strong" while their North American counterparts are "lagging behind", according to a new survey by Aberdeen Standard Investments.